Detalles de la búsqueda
1.
Novel strategies for the mitigation of cytokine release syndrome induced by T cell engaging therapies with a focus on the use of kinase inhibitors.
Oncoimmunology
; 11(1): 2083479, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35694193
2.
Dissecting the mechanism of cytokine release induced by T-cell engagers highlights the contribution of neutrophils.
Oncoimmunology
; 11(1): 2039432, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35186442
3.
JAK and mTOR inhibitors prevent cytokine release while retaining T cell bispecific antibody in vivo efficacy.
J Immunother Cancer
; 10(1)2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35064010
4.
Src/lck inhibitor dasatinib reversibly switches off cytokine release and T cell cytotoxicity following stimulation with T cell bispecific antibodies.
J Immunother Cancer
; 9(7)2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34326166
5.
Identifying Biomarkers of Wharton's Jelly Mesenchymal Stromal Cells Using a Dynamic Metabolic Model: The Cell Passage Effect.
Metabolites
; 8(1)2018 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-29495309
Resultados
1 -
5
de 5
1
Próxima >
>>